Pitcairn CO Baxter International Inc Transaction History

Pitcairn CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$37.32 - $49.29 $4,030 - $5,323	108 Added 0.66%	16,502 $622,000
Q2 2023 Aug 11, 2023	SELL	$39.98 - $47.68 $82,678 - $98,602	-2,068 Reduced 11.2%	16,394 $746,000
Q1 2023 May 05, 2023	BUY	$37.58 - $52.57 $144,044 - $201,500	3,833 Added 26.2%	18,462 $748,000
Q4 2022 Feb 13, 2023	BUY	$49.7 - $57.71 $513,301 - $596,028	10,328 Added 240.13%	14,629 $745,000
Q3 2022 Nov 10, 2022	SELL	$53.86 - $66.8 $26,445 - $32,798	-491 Reduced 10.25%	4,301 $232,000
Q2 2022 Aug 12, 2022	BUY	$63.83 - $80.0 $135,830 - $170,240	2,128 Added 79.88%	4,792 $308,000
Q1 2022 May 12, 2022	SELL	$76.85 - $89.45 $2,305 - $2,683	-30 Reduced 1.11%	2,664 $207,000
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $200,891 - $234,889	2,694 New	2,694 $231,000

996

449M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.